Gene · 10645
Papers2,799
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,799
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Small Molecule Inhibitors and Ligand Directed Degraders of Calcium/Calmodulin Dependent Protein Kinase Kinase 1 and 2 (CaMKK1/2). | J Med Chem | 2023 | 38009718 | PubTator, text mining | PubMed |
| Adiponectin: A Promising Target for the Treatment of Diabetes and Its Complications. | Life (Basel) | 2023 | 38004353 | PubTator, text mining | PubMed |
| A Machine Learning Model Based on microRNAs for the Diagnosis of Essential Hypertension. | Noncoding RNA | 2023 | 37987360 | PubTator, text mining | PubMed |
| Bisdemethoxycurcumin alleviates LPS-induced acute lung injury via activating AMPKα pathway. | BMC Pharmacol Toxicol | 2023 | 37986186 | PubTator, text mining | PubMed |
| What should be the future direction of development in the field of prostate cancer with lung metastasis? | World J Clin Oncol | 2023 | 37970109 | PubTator, text mining | PubMed |
| Potential Schizophrenia Disease-Related Genes Prediction Using Metagraph Representations Based on a Protein-Protein Interaction Keyword Network: Framework Development and Validation. | JMIR Form Res | 2023 | 37966892 | PubTator, text mining | PubMed |
| Physical exercise for a healthy pregnancy: the role of placentokines and exerkines. | J Physiol Sci | 2023 | 37964253 | PubTator, text mining | PubMed |
| Frequent loss-of-function mutations in the AMPK-α2 catalytic subunit suggest a tumour suppressor role in human skin cancers. | Biochem J | 2023 | 37962491 | PubTator, text mining | PubMed |
| Chlorogenic Acid from Burdock Roots Ameliorates Oleic Acid-Induced Steatosis in HepG2 Cells through AMPK/ACC/CPT-1 Pathway. | Molecules | 2023 | 37959676 | PubTator, text mining | PubMed |
Auraptene Enhances AMP-Activated Protein Kinase Phosphorylation and Thereby Inhibits the Proliferation, Migration and Expression of Androgen Receptors and Prostate-Specific Antigens in Prostate Cancer Cells. | Int J Mol Sci | 2023 | 37958994 | PubTator, text mining | PubMed |
| Candidate Genes for IgA Nephropathy in Pediatric Patients: Exome-Wide Association Study. | Int J Mol Sci | 2023 | 37958966 | PubTator, text mining | PubMed |
| Refeeding-associated AMPKγ1 complex activity is a hallmark of health and longevity. | Nat Aging | 2023 | 37957359 | PubTator, text mining | PubMed |
| Crucial role of autophagy in propofol-treated neurological diseases: a comprehensive review. | Front Cell Neurosci | 2023 | 37946715 | PubTator, text mining | PubMed |
| Green synthesis of silver nanoparticles from plant Fagonia cretica and evaluating its anti-diabetic activity through indepth in-vitro and in-vivo analysis. | Front Pharmacol | 2023 | 37936909 | PubTator, text mining | PubMed |
| Melatonin inhibits Japanese encephalitis virus replication and neurotoxicity via calcineurin-autophagy pathways. | BMC Neurosci | 2023 | 37932682 | PubTator, text mining | PubMed |
| STIM1 in tumor cell death: angel or devil? | Cell Death Discov | 2023 | 37932320 | PubTator, text mining | PubMed |
| Sestrin2 in diabetes and diabetic complications. | Front Endocrinol (Lausanne) | 2023 | 37920252 | PubTator, text mining | PubMed |
| D-mannose is a rapid inducer of ACSS2 to trigger rapid and long-lasting antidepressant responses through augmenting BDNF and TPH2 levels. | Transl Psychiatry | 2023 | 37914710 | PubTator, text mining | PubMed |
| Interplay of Extracellular Vesicles and TLR4 Signaling in Hepatocellular Carcinoma Pathophysiology and Therapeutics. | Pharmaceutics | 2023 | 37896221 | PubTator, text mining | PubMed |
| Dual Implications of Nanosilver-Induced Autophagy: Nanotoxicity and Anti-Cancer Effects. | Int J Mol Sci | 2023 | 37895066 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10645/papers?page=12